Cargando…
Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
OBJECTIVES: This study aimed to assess the comparative efficacy of four ablation strategies on the incidence rates of freedom from atrial fibrillation (AF) or atrial tachycardia (AT) through a 3‐year follow‐up in patients with persistent AF. BACKGROUND: The optimal substrate modification strategies...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252615/ https://www.ncbi.nlm.nih.gov/pubmed/33825268 http://dx.doi.org/10.1111/jce.15033 |
_version_ | 1783717339158544384 |
---|---|
author | Hsieh, Yu‐Cheng Lin, Yenn‐Jiang Lo, Men‐Tzung Chen, Yun‐Yu Lin, Chin‐Yu Lin, Chen Chung, Fa‐Po Lo, Li‐Wei Chang, Shih‐Lin Chao, Tze‐Fan Hu, Yu‐Feng Tuan, Ta‐Chuan Liao, Jo‐Nan Wu, Cheng‐I Liu, Chih‐Min Vicera, Jennifer‐Jeanne B. Chen, Chun‐Chao Chin, Chye‐Gen Lugtu, Isaiah C. Chen, Shih‐Ann |
author_facet | Hsieh, Yu‐Cheng Lin, Yenn‐Jiang Lo, Men‐Tzung Chen, Yun‐Yu Lin, Chin‐Yu Lin, Chen Chung, Fa‐Po Lo, Li‐Wei Chang, Shih‐Lin Chao, Tze‐Fan Hu, Yu‐Feng Tuan, Ta‐Chuan Liao, Jo‐Nan Wu, Cheng‐I Liu, Chih‐Min Vicera, Jennifer‐Jeanne B. Chen, Chun‐Chao Chin, Chye‐Gen Lugtu, Isaiah C. Chen, Shih‐Ann |
author_sort | Hsieh, Yu‐Cheng |
collection | PubMed |
description | OBJECTIVES: This study aimed to assess the comparative efficacy of four ablation strategies on the incidence rates of freedom from atrial fibrillation (AF) or atrial tachycardia (AT) through a 3‐year follow‐up in patients with persistent AF. BACKGROUND: The optimal substrate modification strategies using catheter ablation for patients with persistent AF remain unclear. METHODS: Patients with persistent AF were enrolled consecutively to undergo each of four ablation strategies: (a) Group 1 (Gp 1, n = 69), pulmonary vein isolation (PVI) plus rotor ablation assisted by similarity index and phase mapping; (b) Gp 2 (n = 75), PVI plus linear ablations at the left atrium; (c) Gp 3 (n = 42), PVI plus the elimination of complex fractionated atrial electrograms; (d) Gp 4 (n = 67), PVI only. Potential confounders were adjusted via a multivariate survival parametric model. RESULTS: Baseline characteristics were similar across the four groups. At a follow‐up period of 34.9 ± 38.6 months, patients in Gp 1 showed the highest rate of freedom from AF compared with the other three groups (p = .002), while patients in Gp 3 and 4 showed lower rates of freedom from AT than those of the other two groups (p = .006). Independent predictors of recurrence of AF were the ablation strategy (p = .002) and left atrial diameter (LAD) (p = .01). CONCLUSION: In patients with persistent AF, a substrate modification strategy using rotor ablation assisted by similarity index and phase mapping provided a benefit for maintaining sinus rhythm compared with the other strategies. Both ablation strategy and baseline LAD predicted the 3‐year outcomes of freedom from AT/AF |
format | Online Article Text |
id | pubmed-8252615 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82526152021-07-09 Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes Hsieh, Yu‐Cheng Lin, Yenn‐Jiang Lo, Men‐Tzung Chen, Yun‐Yu Lin, Chin‐Yu Lin, Chen Chung, Fa‐Po Lo, Li‐Wei Chang, Shih‐Lin Chao, Tze‐Fan Hu, Yu‐Feng Tuan, Ta‐Chuan Liao, Jo‐Nan Wu, Cheng‐I Liu, Chih‐Min Vicera, Jennifer‐Jeanne B. Chen, Chun‐Chao Chin, Chye‐Gen Lugtu, Isaiah C. Chen, Shih‐Ann J Cardiovasc Electrophysiol Original Articles OBJECTIVES: This study aimed to assess the comparative efficacy of four ablation strategies on the incidence rates of freedom from atrial fibrillation (AF) or atrial tachycardia (AT) through a 3‐year follow‐up in patients with persistent AF. BACKGROUND: The optimal substrate modification strategies using catheter ablation for patients with persistent AF remain unclear. METHODS: Patients with persistent AF were enrolled consecutively to undergo each of four ablation strategies: (a) Group 1 (Gp 1, n = 69), pulmonary vein isolation (PVI) plus rotor ablation assisted by similarity index and phase mapping; (b) Gp 2 (n = 75), PVI plus linear ablations at the left atrium; (c) Gp 3 (n = 42), PVI plus the elimination of complex fractionated atrial electrograms; (d) Gp 4 (n = 67), PVI only. Potential confounders were adjusted via a multivariate survival parametric model. RESULTS: Baseline characteristics were similar across the four groups. At a follow‐up period of 34.9 ± 38.6 months, patients in Gp 1 showed the highest rate of freedom from AF compared with the other three groups (p = .002), while patients in Gp 3 and 4 showed lower rates of freedom from AT than those of the other two groups (p = .006). Independent predictors of recurrence of AF were the ablation strategy (p = .002) and left atrial diameter (LAD) (p = .01). CONCLUSION: In patients with persistent AF, a substrate modification strategy using rotor ablation assisted by similarity index and phase mapping provided a benefit for maintaining sinus rhythm compared with the other strategies. Both ablation strategy and baseline LAD predicted the 3‐year outcomes of freedom from AT/AF John Wiley and Sons Inc. 2021-05-05 2021-06 /pmc/articles/PMC8252615/ /pubmed/33825268 http://dx.doi.org/10.1111/jce.15033 Text en © 2021 The Authors. Journal of Cardiovascular Electrophysiology Published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Hsieh, Yu‐Cheng Lin, Yenn‐Jiang Lo, Men‐Tzung Chen, Yun‐Yu Lin, Chin‐Yu Lin, Chen Chung, Fa‐Po Lo, Li‐Wei Chang, Shih‐Lin Chao, Tze‐Fan Hu, Yu‐Feng Tuan, Ta‐Chuan Liao, Jo‐Nan Wu, Cheng‐I Liu, Chih‐Min Vicera, Jennifer‐Jeanne B. Chen, Chun‐Chao Chin, Chye‐Gen Lugtu, Isaiah C. Chen, Shih‐Ann Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes |
title | Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes |
title_full | Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes |
title_fullStr | Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes |
title_full_unstemmed | Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes |
title_short | Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes |
title_sort | optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252615/ https://www.ncbi.nlm.nih.gov/pubmed/33825268 http://dx.doi.org/10.1111/jce.15033 |
work_keys_str_mv | AT hsiehyucheng optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT linyennjiang optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT lomentzung optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT chenyunyu optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT linchinyu optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT linchen optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT chungfapo optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT loliwei optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT changshihlin optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT chaotzefan optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT huyufeng optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT tuantachuan optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT liaojonan optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT wuchengi optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT liuchihmin optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT vicerajenniferjeanneb optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT chenchunchao optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT chinchyegen optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT lugtuisaiahc optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes AT chenshihann optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes |